Sivakanth Gopakumar et al. 2025. Rituximab in pemphigus and pemphigoid patients: Treatment outcomes and safety profile - A 6-year tertiary center study. Asian Journal of Medical Sciences. 16, 7 (Aug. 2025), 87–91.